Glenmark receives ANDA approval for Dipyridamole capsules
Aspirin and extended-release Dipyridamole capsules, 25 mg/200 mg, is a generic version of Aggrenox Capsules, 25 mg/200 mg, of…
Author
DIL reports a 115 per cent hike in PAT, releases financial report
The company recently released a consolidated financial report for Q4FY19 and FY19, registered a 34 per cent hike in net revenue
Teva Pharm to pay Oklahoma $85 million to settle opioid claims
“Teva is pleased to put the Oklahoma case behind it and remains prepared to vigorously defend claims against the company,…
New beginnings, young hopes
Young start-up leaders from the pharma industry express their hopes and expectations as the new BJP led government kick starts its…
Clariant launches Eqius, a brand of humidity equilibrium stabilizers
The brand encompasses products and technology related to Equilibrium Relative Humidity (ERH) stabilization, made using specially…
OPTEL chosen for US FDA’s DSCSA pilot project for supply chain scrutiny
Serialization and traceability companies selected for the project, like Optel, will test new technologies to develop an…
IPEC Federation publishes its position on supply chain security for Pharmaceutical Grade Excipients
This paper was written in response to many tragedies, even deaths, caused by the use of falsified excipients in recent decades:…
BIAL launches cold chain dedicated services centre in Bengaluru Airport
Kempegowda International Airport, Bengaluru is also the first airport in South India to house a fully operational Drug Control…
Home in on talent, wherever in the world
Mohan Joshi, Independent Management Consultant, writes about how the contemporary leader can, and should, connect across and…
Cipla releases financial results for FY19
The profit after tax (PAT) for Q4 stood at Rs 367 Cr and for FY19 stood at Rs 1528 Cr